Plenary Session
Un podcast de Vinay Prasad, MD MPH
Catégories:
382 Épisodes
-
1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner
Publié: 13/11/2018 -
1.21 Nab-Paclitaxel in CCA, OS of PALOMA-3, Transparency, and Dr. Talal Hilal's Advice for Trainees
Publié: 06/11/2018 -
1.20 Precision Oncology: Some Benefit, Mostly Hype and Mentorship with Dr. Andrae Vandross
Publié: 30/10/2018 -
1.19 BONUS! Introduction to Cancer Drug Policy
Publié: 26/10/2018 -
1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan
Publié: 23/10/2018 -
1.17 BONUS! Interpretation of Cancer Clinical Trials
Publié: 22/10/2018 -
1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong
Publié: 17/10/2018 -
1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare
Publié: 16/10/2018 -
1.14 BONUS! Immunotherapy in Desperation and the Pennington Lecture: Myths of Medicine and Marketing
Publié: 12/10/2018 -
1.13 KEYNOTE-189, Dr. Talal Hilal on MRD, and Medical Education with Dr. Adam Cifu
Publié: 08/10/2018 -
1.12 BONUS! Evidence-Based Medicine Has Been Hijacked in Oncology
Publié: 03/10/2018 -
1.11 Peanut Gallery, Research Parasites, Appendectomies, HRQoL and PFS, Dr. Bishal Gyawali
Publié: 02/10/2018 -
1.10 Criticism via Twitter, PACIFIC, PCI for CAD, and Dr. Rebecca Cooney of The Lancet
Publié: 25/09/2018 -
1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints
Publié: 20/09/2018 -
1.08 Hyperprolific authors, NCCN with Jeff Wagner, and Dr. Renee Dversdal on Ultrasounds
Publié: 14/09/2018 -
1.07 Adjuvant Sunitinib in RCC, future of EBM with Dr. John Mandrola
Publié: 11/09/2018 -
1.06 RELEVANCE, Jenny Gill, and Dr. Catherine Livingston of the Oregon Health Authority
Publié: 07/09/2018 -
1.05 Cost and Efficacy of Cancer Drugs, ECHELON-1, Dr. Derrick Tao, and EBM with Dr. Martha Gerrity
Publié: 05/09/2018 -
1.04: Nutritional Epi, Lenvatinib, Nivo and Ipi for Melanoma, and Dr. Avi O'Glasser
Publié: 30/08/2018 -
1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross
Publié: 21/08/2018
A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California, San Francisco. Tweet your feedback to @Plenary_Session or e-mail [email protected].
